110 related articles for article (PubMed ID: 24512866)
21. Feasibility of a call-in centre to deliver colorectal cancer screening in primary care.
Sewitch MJ; Jiang M; Grad R; Yaffe M; Pavilanis A; Joseph L; Barkun AN; Roper M
Can Fam Physician; 2013 Dec; 59(12):e550-7. PubMed ID: 24336560
[TBL] [Abstract][Full Text] [Related]
22. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
[TBL] [Abstract][Full Text] [Related]
23. Factors affecting compliance in faecal occult blood testing: a cluster randomized study of the faecal immunochemical test versus the guaiac faecal occult test.
Birkenfeld S; Belfer RG; Chared M; Vilkin A; Barchana M; Lifshitz I; Fruchter D; Aronski D; Balicer R; Niv Y; Levi Z
J Med Screen; 2011; 18(3):135-41. PubMed ID: 22045822
[TBL] [Abstract][Full Text] [Related]
24. The effectiveness of the FLU-FOBT program in primary care a randomized trial.
Potter MB; Walsh JM; Yu TM; Gildengorin G; Green LW; McPhee SJ
Am J Prev Med; 2011 Jul; 41(1):9-16. PubMed ID: 21665058
[TBL] [Abstract][Full Text] [Related]
25. Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: the patient perspective.
Deutekom M; van Rossum LG; van Rijn AF; Laheij RJ; Fockens P; Bossuyt PM; Dekker E; Jansen JB
Scand J Gastroenterol; 2010 Nov; 45(11):1345-9. PubMed ID: 20560814
[TBL] [Abstract][Full Text] [Related]
26. Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors.
Carlos RC; Fendrick AM; Abrahamse PH; Dong Q; Patterson SK; Bernstein SJ
Womens Health Issues; 2005; 15(6):249-57. PubMed ID: 16325138
[TBL] [Abstract][Full Text] [Related]
27. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
[TBL] [Abstract][Full Text] [Related]
28. The effect of changing stool collection processes on compliance in nationwide organized screening using a fecal occult blood test (FOBT) in Korea: study protocol for a randomized controlled trial.
Shin HY; Suh M; Baik HW; Choi KS; Park B; Jun JK; Lee CW; Oh JH; Lee YK; Han DS; Lee DH
Trials; 2014 Nov; 15():461. PubMed ID: 25428164
[TBL] [Abstract][Full Text] [Related]
29. Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011.
Honein-AbouHaidar GN; Baxter NN; Moineddin R; Urbach DR; Rabeneck L; Bierman AS
Cancer Epidemiol; 2013 Dec; 37(6):946-56. PubMed ID: 23702337
[TBL] [Abstract][Full Text] [Related]
30. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.
Dekker N; van Rossum LG; Van Vugt-van Pinxteren M; van Stiphout SH; Hermens RP; van Zelst-Stams WA; van Oijen MG; Laheij RJ; Jansen JB; Hoogerbrugge N
Eur J Cancer; 2011 Jul; 47(10):1571-7. PubMed ID: 21367600
[TBL] [Abstract][Full Text] [Related]
31. Manipulating perceptions of colorectal cancer threat: implications for screening intentions and behaviors.
Lipkus IM; Green LG; Marcus A
J Health Commun; 2003; 8(3):213-28. PubMed ID: 12857652
[TBL] [Abstract][Full Text] [Related]
32. Improving fecal occult blood testing compliance using a mailed educational reminder.
Lee JK; Reis V; Liu S; Conn L; Groessl EJ; Ganiats TG; Ho SB
J Gen Intern Med; 2009 Nov; 24(11):1192-7. PubMed ID: 19774423
[TBL] [Abstract][Full Text] [Related]
33. A Systematic Review of Repeat Fecal Occult Blood Tests for Colorectal Cancer Screening.
Murphy CC; Sen A; Watson B; Gupta S; Mayo H; Singal AG
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):278-287. PubMed ID: 31740521
[TBL] [Abstract][Full Text] [Related]
34. Randomized controlled trial of the impact of intensive patient education on compliance with fecal occult blood testing.
Stokamer CL; Tenner CT; Chaudhuri J; Vazquez E; Bini EJ
J Gen Intern Med; 2005 Mar; 20(3):278-82. PubMed ID: 15836533
[TBL] [Abstract][Full Text] [Related]
35. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening.
DeBourcy AC; Lichtenberger S; Felton S; Butterfield KT; Ahnen DJ; Denberg TD
J Gen Intern Med; 2008 Feb; 23(2):169-74. PubMed ID: 18157581
[TBL] [Abstract][Full Text] [Related]
36. Third Annual Fecal Occult Blood Testing in Community Health Clinics.
Arnold CL; Rademaker A; Wolf MS; Liu D; Hancock J; Davis TC
Am J Health Behav; 2016 May; 40(3):302-9. PubMed ID: 27103409
[TBL] [Abstract][Full Text] [Related]
37. Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme.
Malila N; Oivanen T; Hakama M
Z Gastroenterol; 2008 Apr; 46 Suppl 1():S25-8. PubMed ID: 18368636
[TBL] [Abstract][Full Text] [Related]
38. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up.
Scholefield JH; Moss SM; Mangham CM; Whynes DK; Hardcastle JD
Gut; 2012 Jul; 61(7):1036-40. PubMed ID: 22052062
[TBL] [Abstract][Full Text] [Related]
39. Use of interactive voice response to improve colorectal cancer screening.
Cohen-Cline H; Wernli KJ; Bradford SC; Boles-Hall M; Grossman DC
Med Care; 2014 Jun; 52(6):496-9. PubMed ID: 24638119
[TBL] [Abstract][Full Text] [Related]
40. Adherence to colorectal cancer screening in an HMO population.
Myers RE; Trock BJ; Lerman C; Wolf T; Ross E; Engstrom PF
Prev Med; 1990 Sep; 19(5):502-14. PubMed ID: 2235919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
